MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Deerfield Management, Flynn sell more NeuroMetrix stock

Deerfield Management, Flynn sell more NeuroMetrix stock

By

NURO logo

Deerfield Management and general partner James Flynn continued to pare their stakes in NeuroMetrix Inc. (NSDQ:NURO).

The latest sell-off of nearly 332,000 shares, for an average of less than 51 cents, generated $169,000 for Flynn and the hedge fund, leaving a mere 782,000 NURO shares in their hands, according to regulatory filings.

Flynn and Deerfield have sold large portions of NURO stock for the since at least September months. Back in June, when NURO stock was worth $1.91 per share, Deerfield and Flynn together owned just more than 1.8 million shares, according to a federal Securities & Exchange filing. Shares peaked at $3.30 in September 2009, right after Deerfield boosted its stake in NeuroMetrix with a 2.5-million-share, $5 million buy (for $2 per share) during a NeuroMetrix private placement that month. That stake was worth about 19.9 percent of NeuroMetrix.

But the stock has declined steadily since then, prompting Flynn and his fund to ditch nearly 2 million shares since August, for $1.3 million (an average of 63 cents per share), according to regulatory filings. In their latest trade Dec. 14, Flynn and Deerfield sold a collective 332,000 shares, taking a haircut of about $1.49 per share (adding insult to injury, those shares were once worth nearly $1.1 million).

NeuroMetrix has struggled to regain its footing after the Centers for Medicare and Medicaid changed the reimbursement code for nerve conduction studies last year, causing a 22 percent reduction in the average selling price for the electrodes used with its equipment and a 25 percent reduction in the number of electrodes sold during the second quarter. Sales of consumables like the electrodes accounted for 87 percent of total revenues during that quarter.

The poor Q2 results prompted NeuroMetrix to lay off 25 workers — a quarter of its workforce — during the period and make other restructuring moves aimed at saving about $2.5 million a year. In September, the NASDAQ stock market warned NeuroMetrix that it risked a de-listing if it didn’t get its stock back above the exchange’s $1 per share minimum for 10 days.

NeuroMetrix posted a loss of $3.4 million, or 15 cents per diluted share, on sales of $3.4 million during the three months ended Sept. 30. That beat a loss of $9.3 million, or 57 cents per diluted share, on higher sales of $6.3 million during the same period last year.

NURO shares were trading at 53 cents in mid-morning activity today, down 5.2 percent.

In case you missed it

RSS From Medical Design & Outsourcing

  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]
  • The road to a robot: Medtronic’s development process for its Hugo RAS system
    Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they eat a lot, making… […]

Leave a Reply